Clinical Trial Update: Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer [Phase 2]

View source ↗

Summary

A Phase 2 exploratory study evaluating ART-123 for prevention of cancer treatment-related symptoms in postoperative stage II/III colon cancer patients has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• ART-123 (recombinant human soluble thrombomodulin)

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Postoperative Stage II/III Colon Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-04-04